Your browser doesn't support javascript.
loading
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma.
O'Connor, Owen A; Özcan, Muhit; Jacobsen, Eric D; Roncero, Josep M; Trotman, Judith; Demeter, Judit; Masszi, Tamás; Pereira, Juliana; Ramchandren, Radhakrishnan; Beaven, Anne; Caballero, Dolores; Horwitz, Steven M; Lennard, Anne; Turgut, Mehmet; Hamerschlak, Nelson; d'Amore, Francesco A; Foss, Francine; Kim, Won-Seog; Leonard, John P; Zinzani, Pier Luigi; Chiattone, Carlos S; Hsi, Eric D; Trümper, Lorenz; Liu, Hua; Sheldon-Waniga, Emily; Ullmann, Claudio Dansky; Venkatakrishnan, Karthik; Leonard, E Jane; Shustov, Andrei R.
Afiliación
  • O'Connor OA; 1 Columbia University Medical Center, New York, NY.
  • Özcan M; 2 Ankara University Medical School, Ankara, Turkey.
  • Jacobsen ED; 3 Dana-Farber Cancer Institute, Boston, MA.
  • Roncero JM; 4 Institut Català d'Oncologia de Girona, Girona, Spain.
  • Trotman J; 5 Concord Repatriation General Hospital, Concord, New South Wales, Australia.
  • Demeter J; 6 University of Sydney, New South Wales, Australia.
  • Masszi T; 7 Semmelweis Egyetem Általános Orvostudományi Kar, Budapest, Hungary.
  • Pereira J; 8 St. István and St. László Hospital, Budapest, Hungary.
  • Ramchandren R; 9 Semmelweis University, Budapest, Hungary.
  • Beaven A; 10 Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Caballero D; 11 Karmanos Cancer Institute, Detroit, MI.
  • Horwitz SM; 12 Duke University Health System, Durham, NC.
  • Lennard A; 13 Hospital Universitario de Salamanca, Salamanca, Spain.
  • Turgut M; 14 Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hamerschlak N; 15 Northern Centre for Cancer Care, Newcastle upon Tyne, United Kingdom.
  • d'Amore FA; 16 Ondokuz Mayis University, Samsun, Turkey.
  • Foss F; 17 Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
  • Kim WS; 18 Aarhus Universitetshospital, Aarhus, Denmark.
  • Leonard JP; 19 Smilow Cancer Hospital at Yale New Haven, New Haven, CT.
  • Zinzani PL; 20 Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Chiattone CS; 21 Weill Cornell Medical College, New York, NY.
  • Hsi ED; 22 University of Bologna, Bologna, Italy.
  • Trümper L; 23 Santa Casa Medical School, São Paulo, Brazil.
  • Liu H; 24 Cleveland Clinic, Cleveland, OH.
  • Sheldon-Waniga E; 25 University Medical Center Göttingen, Göttingen, Germany.
  • Ullmann CD; 26 Millennium Pharmaceuticals, Cambridge, MA.
  • Venkatakrishnan K; 26 Millennium Pharmaceuticals, Cambridge, MA.
  • Leonard EJ; 26 Millennium Pharmaceuticals, Cambridge, MA.
  • Shustov AR; 26 Millennium Pharmaceuticals, Cambridge, MA.
J Clin Oncol ; 37(8): 613-623, 2019 03 10.
Article en En | MEDLINE | ID: mdl-30707661
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_lymphomas_multiple_myeloma Asunto principal: Pirimidinas / Azepinas / Linfoma de Células T Periférico / Inhibidores de Proteínas Quinasas / Aurora Quinasa A / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_lymphomas_multiple_myeloma Asunto principal: Pirimidinas / Azepinas / Linfoma de Células T Periférico / Inhibidores de Proteínas Quinasas / Aurora Quinasa A / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2019 Tipo del documento: Article